Publications Identification of resistance mechanisms to EGFR treatment in the real world using a clinicogenomic database April 14, 2018 Singal, G, Li, G, Agarwala, V, Kaushik, G, O’Connell, C, Alpha-CobbG, Caron, T, Bourque, D, Guria, A, Frank, S, Frampton, G, Carson, K, Abernethy, A.P., Miller, V.A. AACR Annual Meeting. . https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-com-pdf/AACR-2018-FH-FMI-CGDB-Poster-180411.pdf Authors: Sources:American Association for Cancer Research Annual Meeting Read the research SharePosted inClinical development More publicationsJune 2025Impact of renal function eligibility criteria in clinical trials and real world survival outcomes among patients with metastatic renal cell carcinomaMay 2025Molecular residual disease (MRD) in solid tumorsMay 2025Accrual of racially and ethnically underrepresented populations with multiple myeloma associated with centralized patient screening in a multicenter study
June 2025Impact of renal function eligibility criteria in clinical trials and real world survival outcomes among patients with metastatic renal cell carcinoma
May 2025Accrual of racially and ethnically underrepresented populations with multiple myeloma associated with centralized patient screening in a multicenter study